Cancer Screening

Age- and risk-stratified screening recommendations for the three cancers most often co-managed alongside female pelvic-floor surgery and reconstructive urogynecology. The framework reflects the contemporary multi-society consensus: USPSTF + ACS + ASCCP for cervical, USPSTF + NCCN + ACR + ACP for breast, and the current no-routine-screening / risk-stratified approach for endometrial cancer with a separate Lynch-syndrome / postmenopausal-bleeding workup track.

These pages are oriented toward the specialist co-managing patients alongside their gynecologic-oncology and primary-care colleagues — useful for the urogynecologist counseling a postmenopausal patient about HRT and breast-cancer screening, the reconstructive surgeon evaluating a tamoxifen-treated patient with new postmenopausal bleeding, or the physician deciding whether age-appropriate cervical-cancer screening is current before mesh-based surgery.

• Cervical Cancer ScreeningUSPSTF / ACS / ASCCP screening intervals, primary HPV testing, and post-hysterectomy guidance.
• Breast Cancer ScreeningMammography intervals, supplemental imaging in dense breasts, BRCA-elevated populations.
• Endometrial Cancer ScreeningNo general-population screening; high-risk surveillance (Lynch, tamoxifen, obesity, postmenopausal bleeding workup).